Medicare Enrolled

Dr. Charles Bulfinch, D.O.

Family Medicine · Union Gap, WA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1420 AHTANUM RIDGE DR, Union Gap, WA 98903
5094547700
In practice since 2012 (14 years)
NPI: 1104181221 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bulfinch from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bulfinch? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bulfinch

Dr. Charles Bulfinch is a family medicine specialist in Union Gap, WA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Bulfinch performed 43 Medicare services across 28 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bulfinch received a total of $14,972 from 60 pharmaceutical and/or device companies across 907 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bulfinch is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice ▲ 43 Medicare services $14,972 industry payments

Medicare Practice Summary

Medicare Utilization ↗
43
Medicare services
Bottom 12% in WA for family medicine
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
28
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Prothrombin time test (blood clotting)
A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process.
23 $4 $136
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
20 $3 $63
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$14,972
Total received (2018-2024)
Avg $2,139/year across 7 years
Top 2% in WA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
907
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,537 (97.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$436 (2.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,738
2023
$3,117
2022
$2,543
2021
$2,077
2020
$1,570
2019
$1,306
2018
$1,622

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$404
AstraZeneca Pharmaceuticals LP
$386
ABBVIE INC.
$308
Novo Nordisk Inc
$256
Boehringer Ingelheim Pharmaceuticals, Inc.
$211
Amgen Inc.
$157
Xeris Pharmaceuticals, Inc.
$150
Astellas Pharma US Inc
$114
Novartis Pharmaceuticals Corporation
$97
Exact Sciences Corporation
$74
Bayer Healthcare Pharmaceuticals Inc.
$73
Lundbeck LLC
$69
Takeda Pharmaceuticals U.S.A., Inc.
$65
Daiichi Sankyo Inc.
$63
Abbott Laboratories
$49
ViiV Healthcare Company
$46
Otsuka America Pharmaceutical, Inc.
$39
GlaxoSmithKline, LLC.
$35
Dexcom, Inc.
$29
SANOFI-AVENTIS U.S. LLC
$23
Alnylam Pharmaceuticals Inc.
$22
Sumitomo Pharma America, Inc.
$20
Lilly USA, LLC
$18
Chiesi USA, Inc.
$16
Alexion Pharmaceuticals, Inc.
$14
Top 3 companies account for 40.1% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,845
GlaxoSmithKline, LLC.
$1,188
PFIZER INC.
$1,115
Novo Nordisk Inc
$1,070
Boehringer Ingelheim Pharmaceuticals, Inc.
$814
ABBVIE INC.
$743
AbbVie Inc.
$642
Janssen Pharmaceuticals, Inc
$595
Amgen Inc.
$488
Astellas Pharma US Inc
$470
SANOFI-AVENTIS U.S. LLC
$405
Xeris Pharmaceuticals, Inc.
$362
Abbott Laboratories
$318
Lilly USA, LLC
$310
Novartis Pharmaceuticals Corporation
$266
Bayer HealthCare Pharmaceuticals Inc.
$261
Biohaven Pharmaceuticals, Inc.
$216
Supernus Pharmaceuticals, Inc.
$215
Bayer Healthcare Pharmaceuticals Inc.
$214
Biohaven Pharmaceutical Holding Company Ltd.
$196
Otsuka America Pharmaceutical, Inc.
$192
Exact Sciences Corporation
$181
E.R. Squibb & Sons, L.L.C.
$171
Sunovion Pharmaceuticals Inc.
$166
Takeda Pharmaceuticals U.S.A., Inc.
$136
Sumitomo Pharma America, Inc.
$115
Lundbeck LLC
$112
Daiichi Sankyo Inc.
$97
Allergan Inc.
$79
Shire North American Group Inc
$71
Allergan, Inc.
$60
Teva Pharmaceuticals USA, Inc.
$58
Electromed, Inc.
$57
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$56
Esperion Therapeutics, Inc.
$55
Mylan Specialty L.P.
$52
Alnylam Pharmaceuticals Inc.
$50
ViiV Healthcare Company
$46
Amarin Pharma Inc.
$40
Eisai Inc.
$39
Vanda Pharmaceuticals Inc.
$38
Merck Sharp & Dohme Corporation
$32
Dexcom, Inc.
$29
Kowa Pharmaceuticals America, Inc.
$26
Philips Electronics North America Corporation
$26
UROVANT SCIENCES INC
$25
Radius Health, Inc.
$25
Echosens North America, Inc.
$21
Genentech USA, Inc.
$18
Phadia US Inc.
$18
Celgene Corporation
$17
SANOFI PASTEUR INC.
$17
Chiesi USA, Inc.
$16
IRONWOOD PHARMACEUTICALS, INC
$15
Corcept Therapeutics
$14
Alexion Pharmaceuticals, Inc.
$14
Horizon Therapeutics plc
$14
ITI, Inc.
$13
Alfasigma USA, Inc.
$13
Hologic, LLC
$13
Top 3 companies account for 34.4% of all-time payments
Associated products mentioned in payments ›
AJOVY · ANORO · ANORO ELLIPTA · APRETUDE · AREXVY · Aimovig · AirDuo Digihaler · BASAGLAR · BEXSERO · BREO · BREZTRI · BREZTRI AEROSPHERE · BRINTELLIX · BYDUREON · BYSTOLIC · CAMZYOS · CAPLYTA · CHANTIX · COMIRNATY · Cologuard Collection Kit · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · ENTYVIO · EVENITY · FARXIGA · FASENRA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FibroScan · FreeStyle Libre · FreeStyle Libre 2 · GEMTESA · GIVLAARI · GVOKE HYPOPEN · GVOKE PFS · HETLIOZ · INJECTAFER · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · KEVEYIS · Kerendia · Korlym · LEQVIO · LINZESS · LOKELMA · LYRICA · Linzess · Livalo · MENQUADFI · MYCAPSSA · MYDAYIS · MYFEMBREE · NEXLETOL · NUCALA · NURTEC ODT · OXLUMO · Otezla · Ozempic · PAXLOVID · PREMARIN · Prolia · QELBREE · QULIPTA · RECORLEV · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SMARTVEST · SOLIQUA · SOLIQUA 100/33 · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · STRENSIQ · SYMBICORT · Saxenda · TEPEZZA · THINPREP 2000 PROCESSOR · TOUJEO · TOVIAZ · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULANCE · TRULICITY · TZIELD · Tresiba · Tymlos · UBRELVY · VIBERZI · VIIBRYD · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · Wegovy · Wellcentive Undiv · XARELTO · XIFAXAN · Xofluza · YUPELRI · Yupelri · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in WA.

Looking for a family medicine specialist in Union Gap?
Compare family medicine physicians in the Union Gap area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
122
Per 100K population
47.5
County median income
$68,015
Nearest hospital
YAKIMA VALLEY MEMORIAL
19.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Bulfinch is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 2% of WA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Bulfinch experienced with prothrombin time test (blood clotting)?
Based on Medicare claims data, Dr. Bulfinch performed 23 prothrombin time test (blood clotting) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bulfinch receive payments from pharmaceutical companies?
Yes. Dr. Bulfinch received a total of $14,972 from 60 companies across 907 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bulfinch's costs compare to other family medicine physicians in Union Gap?
Dr. Bulfinch's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bulfinch) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →